Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery
The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs against diseases of the central nervous system (CNS). Because of this barrier there is still a huge unmet need for the treatment of these diseases, despite years of research efforts across the pharmac...
Main Authors: | Axel H. Meyer, Thomas M. Feldsien, Mario Mezler, Christopher Untucht, Ramakrishna Venugopalan, Didier R. Lefebvre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/4/1100 |
Similar Items
-
Exosomes as CNS Drug Delivery Tools and Their Applications
by: Ke Sun, et al.
Published: (2022-10-01) -
Nanotechnology-based drug delivery for the treatment of CNS disorders
by: Mittal Khushi R., et al.
Published: (2022-12-01) -
Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
by: Katherine Elizabeth Warren
Published: (2018-07-01) -
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
by: Li H, et al.
Published: (2023-01-01) -
Customizing delivery nano-vehicles for precise brain tumor therapy
by: Yang-Bao Miao, et al.
Published: (2023-01-01)